 "Pharma, medicine, drugs, Pharmaceuticals")
Dr Reddy's Laboratories on Tuesday said it has launched in the US generic Ziprasidone Mesylate for injection used for treatment of acute agitation in schizophrenic patients.
The company launched Ziprasidone Mesylate for injection, 20 mg/ml single dose vials, the therapeutic generic equivalent of Geodon Injections, following the approval by the US Food and Drug Administration(US FDA). The drug is used to treat occurrences of severe agitation in patients with schizophrenia.
"We are pleased to bring the first generic of Ziprasidone Mesylate for injection to market for patients who will
